-+ 0.00%
-+ 0.00%
-+ 0.00%

Apnimed Q3 EPS $(1.05) Misses $(0.59) Estimate, Sales $2.480M Down From $8.802M YoY

Benzinga·11/16/2026 13:32:47
Listen to the news
Apnimed (NASDAQ:APMD) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.59) by 77.97 percent. This is a 42.62 percent increase over losses of $(1.83) per share from the same period last year. The company reported $2.480 million in sales this quarter. This is a 71.82 percent decrease over sales of $8.802 million the same period last year.